Cargando…
SARS-CoV-2 neutralizing capacity among blood donors without prior COVID-19 symptomatic history vs. blood donors with prior COVID-19 symptomatic history: A comparative study
INTRODUCTION: Though moderate to severely ill COVID-19 patients are being treated using COVID Convalescent plasma across the world, there is a lack of standardization or information about the relative neutralizing capacity of antibodies from convalescent plasma donors. The current study aimed to com...
Autores principales: | Ravula, Ushasree., Chunchu, Srinivasa Rao, Mooli, Srujaleswari, Naik, Ravi, Sarangapati, Pandu Ranga Rao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Société française de transfusion sanguine (SFTS). Published by Elsevier Masson SAS.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8839806/ https://www.ncbi.nlm.nih.gov/pubmed/35167958 http://dx.doi.org/10.1016/j.tracli.2022.02.004 |
Ejemplares similares
-
SARS-CoV-2 Seroprevalence Among Whole Blood Donors During First Wave of Covid-19 Pandemic in India
por: Chunchu, Srinivasa Rao, et al.
Publicado: (2022) -
Whole blood derived covid convalescent plasma: An economical option among developing countries
por: Ravula, Ushasree, et al.
Publicado: (2021) -
Donors With a Prior History of Cancer: Factors of Non-Utilization of Kidneys for Transplantation
por: Lim, Wai H., et al.
Publicado: (2023) -
Using the COVID-19 to influenza ratio to estimate the numbers of symptomatic COVID-19 cases in Wuhan prior to the lockdown
por: Du, Zhanwei, et al.
Publicado: (2020) -
COVID-19 related callback in blood donors; Outcomes in blood donors and patients
por: Balagholi, Sahar, et al.
Publicado: (2021)